We confirmed that transfection with miR-34a resulted in a significant decrease in the protein and mRNA levels of ATM, EGFR, Bcl2, c-Met and UGCG in glioblastoma cells (Fig. 4a and Additional file 6: Figure S3). The gene discussed is BCL2; the disease is glioblastoma.